ISSN: 2321 – 0494


News Flash

NL-1-2014-LETTER-1 CELLS...

www.ijfstonline.org CELLS IN LIVING MICE 'REPROGRAMMED' TO EMBRYONIC-LIKE STATE S. Sharmilabanu.,(B.Pharm Final Year), Vels university. Stem cells Stem cells are undifferentiated biological...

Read more...

NL-1-2014-LETTER-2 -...

www.ijfstonline.org BETTER ACTION ON WARFARIN ON YOUNGER HEART FAILURE PATIENTS   By:  Dhulipala Sowmya.,(B-Pharm II year),Vels University Warfarin may be more beneficial than aspirin in...

Read more...

...

  www.ijfstonline.org EFFECTS OF POLLUTION ON HUMAN HEALTH By:Rohin kumar.,(B-Pharm I Year)Vels Uuniversity The overview of main health effects on humans from some common types of pollution....

Read more...

NL-1-2014-LETTER-4...

www.ijfstonline.org PROGERIA By:  Prithivi Logathasan,(B-Pharm III Year),Vels University HGPS (Hutchinson-Gilford Progeria Syndrome) or Progeria is an extremely rare, fatal genetic condition....

Read more...

NL-1-2014-LETTER-5...

www.ijfstonline.org OBESE MADE LEAN BY LEANS By:  S.Santhya.,(B-Pharm-Final Year)Vels University The Microbes from Lean People Act as Anti-Obesity Agents. Bugs that lurk in the guts of slim...

Read more...

User Login



I2OR index

Who's Online

We have 8 guests online
Home
NL-2- Letter-2016-Regular “Aspirin” use may reduce “Cancer” Risk PDF Print E-mail

Regular “Aspirin” use may reduce “Cancer” Risk

www.ijfstonline.org

By S.Sangeetha, B.Pharm, 1st year, School of Pharmaceutical Sciences, Vels University

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Objective

Regular usage of aspirin is likely to reduce to overall risk of cancer, a reduction that primarily reflects a lower risk of colorectal cancer and other tumors of the gastrointestinal tracts, finds a new study.

The recurrent use of aspirin reduced the risk of colorectal cancer by 19 percent.

RECQUIREMENT:

The recurrent use of aspirin reduces the risk of any gastrointestinal caner by 15 percent.  No reduction was seen in the risk of breast prostate or lung cancer

However, the use of aspirin may complement, but not replace the preventive benefits of colonoscopy and other methods of cancer screening, warned the researchers.

“Our findings imply that Aspirin use is expected to prevent a significant number of colorectal cancers beyond those that would be prevented by screening and may have even greater benefit in settings in which the resources to devote to cancer screening are lacking”

Said one of the researchers Andrew chan, associate Professor at Harvard university in U.S.A

USES :

A regular usage of aspirin could prevent around 30,000 gastrointestinal tract tumors in the US each year.

It could prevent an additional 7,500 colorectal tumors among US adults over 50, who have endoscopic screening

The research team analyzed 32 years of data from almost 136,000 participants in the Nurses’ Health study and the Health professional’s follow-up study.

The findings of the study published online first in JAMA ONCOLOGY.

DOSAGE :

The results showed that people, who look either a standard or a low-dose aspirin tablet at least twice a week, ad a 3 percent lower risk of cancer than those who didn’t report regular aspirin use.

CONCLUSION

The researchers stressed the patients should be well informed about the potential side effects of regular aspirin treatment and continue their regular screening tests. But, aspirin should not be viewed as a substitute for colonoscopy or other cancer screening test, the researchers concluded.

 

 

Latest News

Popular

Indexing

News Letter


© 2012 Internationaljournalofindiansciences.org. All Rights Reserved. Powered by JK Webdesigns.

Free Counters